by American Association for Cancer Research Remetinostat, a topical cream and first-in-class inhibitor of histone deacetylation showed signs of clinical efficacy in patients with basal cell carcinoma, according to results from a phase II clinical trial published in Clinical Cancer Research. Basal cell carcinoma (BCC) is the most common form of skin cancer and is typically treated...
Tag: <span>Basal cell carcinoma</span>
Post
Topical skin cream for treatment of basal cell carcinoma shows promise as an alternative to surgery — ScienceDaily
Basal cell carcinoma (BCC), a type of skin cancer, is the most common form of human cancer. With a growing aging population, BCC rates are climbing at an alarming rate, with reported cases rising by as much as 10% per year. Rising demand makes a simple and effective treatment for BCC appealing to both practitioners...